The Institute of Cancer Research (ICR), London, is one of the world’s most 
influential cancer research institutes, with an outstanding record of 
achievement dating back more than 100 years. We provided the first convincing 
evidence that DNA damage is the basic cause of cancer, laying the foundation 
for the now universally accepted idea that cancer is a genetic disease. Today, 
The ICR leads the world at isolating cancer-related genes and discovering new 
targeted drugs for personalised cancer treatment. Together with our hospital 
partner The Royal Marsden, we are rated in the top four centres for cancer 
research and treatment worldwide. As well as being a world-class institute, we 
are a college of the University of London. We came top in the league table of 
university research quality compiled from the Research Excellence Framework and 
second in 2021 (REF 2014 and 2021). The ICR is committed to attracting, 
developing and retaining the best minds in the world to join us in our mission 
– to make the discoveries that defeat cancer.

The Centre for Cancer Drug Discovery (CCDD), within the Division of Cancer 
Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising 
around 160 staff dedicated to the discovery and development of novel 
therapeutics for the treatment of cancer. The CCDD’s exciting goal is to 
discover high quality small molecule drug candidates and to progress these to 
clinical trial. All the scientific disciplines are in place to make this 
possible, including medicinal chemistry, biology, structural biology, assay 
scientists, drug metabolism and clinical specialists. This is an exciting and 
fast-moving research setup and offers the opportunity to work within a 
multi-disciplinary environment using state-of-the-art techniques and equipment.

Two Higher Scientific Officer positions in recombinant protein purification are 
available in Dr Rob van Montfort’s Hit Discovery and Structural Design Team 
within the CCDD (see the links below). The team uses biochemical and 
biophysical assays to perform small-molecule high-throughput screening and 
fragment-based hit discovery, coupled with X-ray crystallography to enable 
structure-based drug design. These methodologies are underpinned by 
state-of-the art protein expression, purification and biophysical 
characterisation capabilities, allowing for the generation of large quantities 
of high-quality protein targets. We are seeking highly motivated scientists to 
join the team, with expertise in protein expression, protein purification and 
biophysics. The successful candidates will be carrying out protein expression 
and purification as part of the CCDD’s research programmes and will be 
responsible for establishing biophysical assays such as Surface Plasmon 
Resonance (SPR), Thermal Shift Assay (TSA) and ligand-observed NMR (LO-NMR) to 
characterise these protein targets and their protein-protein and protein-ligand 
interactions. The HSOs will be integral members of multidisciplinary project 
teams within the CCDD at the ICR Sutton site, and will interact closely with 
biologists, computational chemists, medicinal chemists, assay scientists and 
structural biologists.

Applicants must have at least a BSc in a biochemistry or related biological 
subject, and ideally an MSc or PhD. Experience and demonstrable skills in 
molecular biology, protein expression in E. coli and protein purification are 
essential. The starting salary will be in the range £37,050 to £45,732 p.a. 
inclusive (based on previous postdoctoral experience).

The posts are offered on a fixed term contract of 2 years. Informal enquiries 
to rob.vanmontf...@icr.ac.uk<mailto:rob.vanmontf...@icr.ac.uk> or 
yann-vai.lebi...@icr.ac.uk<mailto:yann-vai.lebi...@icr.ac.uk>.

Please DO NOT send your application to Dr van Montfort or Dr Le Bihan, but 
apply via the e-recruitment system on our website 
www.icr.ac.uk<http://www.icr.ac.uk>.
For more details see the following links:

Higher Scientific Officer – Protein production, purification and biophysics
https://jobs.icr.ac.uk/vacancies/838/higher-scientific-officer--protein-production-purification-and-biophysics.html
Experience and demonstrable skills in molecular biology, protein expression in 
E. coli and protein purification are essential. Demonstrable practical 
experience of biophysical techniques (SPR, TSA and/or LO-NMR) is desirable.  
Experience in protein expression in insect and/or mammalian cells is also 
highly desirable.

Higher Scientific Officer – Protein production and purification
https://jobs.icr.ac.uk/vacancies/837/higher-scientific-officer--protein-production-and-purification.html
Experience and demonstrable skills in molecular biology, protein expression in 
E. coli and insect cells and protein purification are essential. Demonstrable 
practical experience of biophysical techniques (such as DLS, TSA, ITC and/or 
SPR) would be highly desirable.


Dr. Rob van Montfort
Reader in Structural Biology and Cancer Drug Discovery
Team Leader Hit Discovery and Structural Design
Centre for Cancer Drug Discovery, Divisions of Cancer Therapeutics and 
Structural Biology
The Institute of Cancer Research
15 Cotswold Road
Sutton SM2 5NG
UK

Tel:
+44-(0)20-8722-4364
Email: rob.vanmontf...@icr.ac.uk<mailto:rob.vanmontf...@icr.ac.uk>


The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company 
Limited by Guarantee, Registered in England under Company No. 534147 with its 
Registered Office at 123 Old Brompton Road, London SW7 3RP.

This e-mail message is confidential and for use by the addressee only. If the 
message is received by anyone other than the addressee, please return the 
message to the sender by replying to it and then delete the message from your 
computer and network.

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to